R-CHOP in the treatment of DLBCL: Single institution experience from north India.

被引：0
|
作者：
Vaid, AK [1 ]
Gupta, S [1 ]
Doval, DC [1 ]
Talwar, V [1 ]
Gupta, R [1 ]
Sharma, JB [1 ]
Chaturvedi, AK [1 ]
Prakesh, N [1 ]
机构：
[1] Rajiv Gandhi Canc Inst & Res Ctr, Delhi, India
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
10.1182/blood.V106.11.4773.4773
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4773
引用
收藏
页码：273B / 273B
页数：1
相关论文
共 50 条
  • [31] An immunocompetent, spontaneous mouse model of DLBCL for studying the response to R-CHOP and identifying new treatment targets
    Maybury, B.
    Fitzgibbon, J.
    Calado, D.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 110 - 111
  • [32] CD24 Contributes to Treatment Effect in ABC-DLBCL Patients with R-CHOP Resistance
    Qiao, Li-Yan
    Li, Han-Bing
    Zhang, Yue
    Shen, Di
    Liu, Peng
    Che, Yi-Qun
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2021, 14 : 591 - 599
  • [33] Characterising Tumour and Microenvironmental Responses to R-CHOP in Immunocompetent Mouse Models of DLBCL
    Maybury, Bernard D.
    Bewicke-Copley, Findlay
    Peter, Johnson
    Fitzgibbon, Jude
    Calado, Dinis Pedro
    BLOOD, 2021, 138
  • [34] 80% Dose R-CHOP Is Suitable Chemotherapy for Very Elderly Patients with DLBCL
    Takahashi, Anna
    Mishima, Yuko
    Inoue, Norihito
    Kusano, Yoshiharu
    Gunji, Tadahiro
    Ueda, Kyoko
    Nishimura, Noriko
    Nitta, Hideaki
    Yokoyama, Masahiro
    Tsuyama, Naoko
    Takeuchi, Kengo
    Terui, Yasuhito
    Hatake, Kiyohiko
    BLOOD, 2015, 126 (23)
  • [35] A DLBCL PATIENT ACCOMPANIED BY ITP TREATED WITH R-CHOP AND THROMBOPOIETIN RECEPTOR AGONIST
    Kurita, D.
    Hatta, Y.
    Kobayashi, Y.
    Hirabayashi, Y.
    Kiso, S.
    Kodaira, H.
    Takahashi, H.
    Miura, K.
    Nakagawa, M.
    Takeuchi, J.
    ANNALS OF ONCOLOGY, 2013, 24
  • [36] Prognostic Differences Based on Ethnicity in Patients with DLBCL Treated with R-CHOP Therapy
    Reid, Jack
    Lee, Winston
    Soma, Lori
    Perry, Anamarija
    Bedell, Victoria
    Hsueh, Julia
    Wu, Xiwei
    Wang, Jinhui
    Weisenburger, Dennis
    Song, Joo
    LABORATORY INVESTIGATION, 2024, 104 (03) : S1470 - S1471
  • [37] A perspective on improving the R-CHOP regimen: from Mega-CHOP to ROBUST R-CHOP, the PHOENIX is yet to rise
    Lue, Jennifer K.
    O'Connor, Owen A.
    LANCET HAEMATOLOGY, 2020, 7 (11): : E838 - E850
  • [38] A non-randomized risk-adjusted comparison of lenalidomide plus R-CHOP versus R-CHOP for MYC-rearranged DLBCL patients
    de Jonge, A. Vera
    van Werkhoven, Erik
    Dinmohamed, Avinash G.
    Nijland, Marcel
    Zwinderman, Aeilko H.
    Bossuyt, Patrick M.
    Veldhuis, Martine S.
    Rutten, Emma G. G. M.
    Mous, Rogier
    Vermaat, Joost S. P.
    Sandberg, Yorick
    de Jongh, Eva
    Bilgin, Yavuz M.
    Boersma, Rinske
    Koene, Harry
    Kersten, Marie Jose
    de Jong, Daphne
    Chamuleau, Martine E. D.
    BLOOD CANCER JOURNAL, 2023, 13 (01)
  • [39] DA-R-EPOCH vs R-CHOP in DLBCL: How Do We Choose?
    Major, Ajay
    Smith, Sonali M.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (11) : 698 - +
  • [40] Immunochemotherapy (R-CHOP, R-EPOCH) in the treatment of diffuse B-cell large cell lymphomas (DLCL) - A single institution expirience
    Mihaljevic, B
    Nedeljkov-Jancic, R
    Jankovic, S
    Cemerikic, V
    Petrovic, M
    Boskovic, D
    ANNALS OF ONCOLOGY, 2005, 16 : 178 - 178
12345